Literature DB >> 22714673

Methicillin-resistant Staphylococcus aureus-related glomerulonephritis in a child.

Takahisa Kimata1, Shoji Tsuji1, Ken Yoshimura1, Hiroyasu Tsukaguchi2, Kazunari Kaneko3.   

Abstract

BACKGROUND: Methicillin-resistant Staphylococcus aureus-associated glomerulonephritis (MRSA-GN), a syndrome in which superantigens play an important role in the pathogenesis of the infection, has been well described in adult patients but not previously recognized in children. CASE DIAGNOSIS/TREATMENT: We report the case of a 6-year-old girl with MRSA-GN. She presented multiple malformations, including tracheal stenosis necessitating tracheotomy. She was admitted to our hospital because of acute pneumonia caused by a MRSA infection and was found to have proteinuria and abnormal renal function. MRSA was detected in her sputum, and this MRSA isolate produced toxic shock syndrome toxin-1, which acts as a superantigen and stimulates Vβ2(+) T cells. A blood test revealed that the number of circulating Vβ2(+) T cells expressing CD45RO, a marker of activation, was increased along with a concomitant elevation in the levels of serum immunoglobulins. Both are hallmarks of MRSA-GN. The eradication of MRSA using appropriate antibiotics resulted in the disappearance of the proteinuria; in contrast, corticosteroid treatment failed. To the best of our knowledge, this is the youngest patient to be diagnosed with MRSA-GN.
CONCLUSIONS: In summary, there should be a high index of suspicion for MRSA-GN, even in the very young, in order to avoid the unnecessary use of immune suppressants in this context.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22714673     DOI: 10.1007/s00467-012-2229-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

1.  Methycillin-resistant Staphylococcus aureus-related glomerulonephritis.

Authors:  M Kobayashi; A Koyama
Journal:  Nephrol Dial Transplant       Date:  1999       Impact factor: 5.992

Review 2.  Role of superantigens in human disease.

Authors:  P M Schlievert
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

3.  Glomerulonephritis after methicillin-resistant Staphylococcus aureus infection resulting in end-stage renal failure.

Authors:  Y Yamashita; T Tanase; Y Terada; H Tamura; T Akiba; H Inoue; T Ida; S Sasaki; F Marumo; Y Nakamoto
Journal:  Intern Med       Date:  2001-05       Impact factor: 1.271

4.  A case of superantigen-related glomerulonephritis after methicillin-resistant Staphylococcus aureus (MRSA) infection.

Authors:  K Yoh; M Kobayashi; A Hirayama; K Hirayama; N Yamaguchi; S Nagase; A Koyama
Journal:  Clin Nephrol       Date:  1997-11       Impact factor: 0.975

5.  Favorable outcome of crescentic IgA nephropathy associated with methicillin-resistant Staphylococcus aureus infection.

Authors:  Yueh-Ren Chen; Yao-Ko Wen
Journal:  Ren Fail       Date:  2011       Impact factor: 2.606

6.  Diffuse proliferative glomerulonephritis and acute renal failure associated with acute staphylococcal osteomyelitis.

Authors:  M D Griffin; J Björnsson; S B Erickson
Journal:  J Am Soc Nephrol       Date:  1997-10       Impact factor: 10.121

Review 7.  Successful treatment of post-MRSA infection glomerulonephritis with steroid therapy.

Authors:  S Okuyama; H Wakui; N Maki; J Kuroki; T Nishinari; K Asakura; A Komatsuda; K Sawada
Journal:  Clin Nephrol       Date:  2008-10       Impact factor: 0.975

8.  Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen.

Authors:  A Koyama; M Kobayashi; N Yamaguchi; K Yamagata; K Takano; M Nakajima; F Irie; M Goto; M Igarashi; T Iitsuka
Journal:  Kidney Int       Date:  1995-01       Impact factor: 10.612

9.  Effective antibiotic treatment of methicillin-resistant Staphylococcus aureus-associated glomerulonephritis.

Authors:  Yasushi Nagaba; Yoshiyuki Hiki; Togo Aoyama; Takashi Sano; Takatoshi Matsuo; Takeshi Shimizu; Sumio Tateno; Hisato Sakamoto; Kouju Kamata; Hidekazu Shigematsu; Masaaki Higashihara; Yutaka Kobayashi
Journal:  Nephron       Date:  2002-10       Impact factor: 2.847

10.  Bullous pemphigoid associated with acute glomerulonephritis.

Authors:  M A Barnadas; C Gelpí; V Rocamora; E Baró; J Ballarín; C Nadal; A Bielsa; J Aróstegui; A Alomar
Journal:  Br J Dermatol       Date:  1998-05       Impact factor: 9.302

View more
  5 in total

Review 1.  Staphylococcus aureus Infection-Related Glomerulonephritis with Dominant IgA Deposition.

Authors:  Mamiko Takayasu; Kouichi Hirayama; Homare Shimohata; Masaki Kobayashi; Akio Koyama
Journal:  Int J Mol Sci       Date:  2022-07-05       Impact factor: 6.208

2.  Update on Epidemiology and Treatment of MRSA Infections in Children.

Authors:  Michael Z David; Robert S Daum
Journal:  Curr Pediatr Rep       Date:  2013-09-01

Review 3.  Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis.

Authors:  Anjali A Satoskar; Samir V Parikh; Tibor Nadasdy
Journal:  Nat Rev Nephrol       Date:  2019-08-09       Impact factor: 28.314

4.  Clinical, Pathological, and Prognostic Characteristics of Glomerulonephritis Related to Staphylococcal Infection.

Authors:  Si-Yang Wang; Ru Bu; Qi Zhang; Shuang Liang; Jie Wu; Xue-Guang Zhang Shu-Wen Liu; Guang-Yan Cai; Xiang-Mei Chen
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Clinicopathologic features of infection-related glomerulonephritis with IgA deposits: a French Nationwide study.

Authors:  Elodie Miquelestorena-Standley; Charlotte Jaulerry; Marie-Christine Machet; Nolwenn Rabot; Christelle Barbet; Aurélie Hummel; Alexandre Karras; Cyril Garrouste; Thomas Crepin; Didier Ducloux; Maud Cousin; Catherine Albert; Joseph Rivalan; Emilie Cornec-Le Gall; François Pourreau; Clément Deltombe; Dominique Nochy; Nora Szlavik; Sophie Felix; Anne Croué; David Buob; Nathalie Rioux-Leclerc; Laurent Doucet; Jean-Michel Goujon; Karine Renaudin; Emmanuelle Blanchard; Sébastien Eymieux; Marion Rabant; Jean-Michel Halimi
Journal:  Diagn Pathol       Date:  2020-05-27       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.